NYSE ARCA | ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index.
The index seeks to track the performance of the common stock ofU. S. exchange-listed biotechnology companies with at least one drug therapy approved by theU. S.
Food and Drug Administration (FDA) for marketing.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 3.67% |
| DCPH | Deciphera Pharmaceuticals LLC | Healthcare | Drug Manufacturers - Specialty & Generic | 3.02% |
| ADMA | ADMA Biologics Inc | Healthcare | Biotechnology | 2.92% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 2.77% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 2.41% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 2.39% |
| AUP | Aurinia Pharmaceuticals Inc | Technology | Technical & System Software | 2.32% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.24% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 2.16% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.11% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 2.10% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 2.07% |
| ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 2.03% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.01% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.92% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.86% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.83% |
| AGIO | Agios Pharm | Healthcare | Biotechnology | 1.78% |
| BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Biotechnology | 1.77% |
| TBPH | Theravance Biopharma Inc | Healthcare | Biotechnology | 1.77% |